Actively Recruiting

Age: 18Years - 45Years
All Genders
Healthy Volunteers
ID07624747

Cerebral Blood Flow and Neurocognitive Performance in Adults Undergoing Gender-affirming Hormone Therapy

Led by University of Wisconsin, Madison · Updated on 2026-06-03

72

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to understand how gender affirming hormone therapy (GAHT) affects the brains of transgender adults. The study will investigate changes in cerebral blood flow, brain structure, connectivity, and cognitive functions such as memory, attention, executive function, and processing speed. Researchers will compare these brain changes in transgender males and females over the first few months after starting GAHT. Participants will undergo two main sets of evaluations: one before beginning GAHT and another 4 to 6 months after continuous hormone therapy. These evaluations include magnetic resonance imaging (MRI) scans to assess brain structure and function, cognitive and health tests to measure body composition and neurocognitive performance, and an optional graded exercise test to assess cardiorespiratory fitness. During the study, participants will have MRI scans involving structural brain imaging and scans during cognitive tasks and acute stress response. They will complete cognitive tasks using the NIH Toolbox and have body composition scans. Optional exercise testing may be performed. Researchers will monitor changes in brain blood flow, structure, connectivity, and various cognitive tests over the study period, with the entire observation lasting up to 6 months after starting GAHT.

CONDITIONS

Brief Title

Brain Health in Transgender Adults

Who Can Participate

Age: 18Years - 45Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Intention to undergo gender affirming hormone therapy (GAHT)
  • Age between 18 and 45 years
  • All genders eligible
Not Eligible

You will not qualify if you...

  • Body mass index (BMI) greater than 40 kg/m2
  • Age greater than 45 years
  • Blood pressure greater than 140/90 (stage II hypertension)
  • Current diagnosis of type II diabetes
  • History of traumatic brain injury, concussion, stroke, or seizures
  • Post-menopausal status
  • Previous use of hormone therapy medications
  • Self-reported pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants undergo baseline assessments including MRI scans, cognition and health tests, and optional graded exercise tests to measure brain structure, function, and physical fitness before starting hormone therapy.

1 baseline visit (in-person) lasting approximately 1.5 hours for MRI plus additional time for cognitive and optional exercise tests

Long-term Monitoring

Duration - 4 to 6 months

Participants undergo continuous gender-affirming hormone therapy (GAHT) and are monitored for changes in cerebral blood flow, brain structure, connectivity, cognitive function, body composition, and blood markers over 4 to 6 months.

No scheduled visits during hormone therapy; monitoring occurs through assessments at baseline and after 4 to 6 months

Diagnostic Evaluation

Duration - 1 day

Participants complete follow-up assessments including MRI scans, cognition and health tests, and optional graded exercise tests to evaluate changes after 4 to 6 months of continuous hormone therapy.

1 follow-up visit (in-person) lasting approximately 1.5 hours for MRI plus additional time for cognitive and optional exercise tests

Trial Site Locations

Total: 1 location

1

UW School of Medicine and Public Health

Madison, Wisconsin, United States, 53792

Actively Recruiting

Loading map...

Research Team

S

Shawn Bolin, MS

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Development of Effective, Opioid Sparing Techniques for Peri...

Gender Dysphoria

Actively Recruiting

1 location

Early Mental Response to Hormonal Treatment in Transgender M...

Gender Dysphoria

Actively Recruiting

1 location

The Effect of Nitropaste in Chest Masculinizing Surgery: Ran...

Gender Dysphoria

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here